Dr. Kahn was one of the researchers who studied the effects of Lybalvi in clinical trials.
What Is Lybalvi?
Lybalvi, which is taken by mouth, was found to be well tolerated in both studies.
Lybalvi should not be used by people who are taking opioids or going through acute opioid withdrawal.
Lybalvi is anticipated to be available for patients in late 2021, Alkermes said in a press release.
The amount of weight gain due to each drug ranged from mild to severe, the researchers wrote.
Christina Vogt is an award-winning editor covering mental health conditions for Everyday Health.
